HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Right On Risk Approach, Slow On Food Protection Progress – GAO

This article was originally published in The Tan Sheet

Executive Summary

The Government Accountability Office cites significant cost savings in its endorsement of FDA's risk-based approach to import safety inspections, but says the agency has yet to deliver on plans for tightening its protection of the U.S. food supply

You may also be interested in...

FDA Foreign Offices Are Only The Start To Improving Import Safety – Experts

FDA needs the cooperation of foreign governments to improve import safety, but still could be overwhelmed by rapidly expanding industry overseas and a lack of resources, according to food and drug industry stakeholders

Import Safety Pilot Casts Global Net For Inspecting Drug Manufacturers

The U.S. is launching a pilot program with Australia and the European Union to "spread our inspection net wider" for drug manufacturing facilities, according to Health and Human Services Secretary Michael Leavitt

GAO vote of confidence

Two independent peer reviews give the Government Accountability Office "clean opinions" on its quality assurance system to produce congressional reports and testimony, the office announces June 30. An international peer review team led by the office of the Auditor General of Canada examined GAO's performance audit work, and the accounting firm KPMG assessed its financial audit work and attestation engagements. GAO seeks to improve the performance of the federal government. Recently, the office released a report on FDA that cites significant costs savings in the agency's risk-based approach to import safety inspections, but says the agency has yet to tighten its U.S. food supply protection (1"The Tan Sheet" June 16, 2008, p. 14)...

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts